MedPath

Unified Protocol for Emotional Problems in Victims of the Armed Conflict in Colombia

Not Applicable
Completed
Conditions
Emotional Disorder
Interventions
Behavioral: Unified Protocol
Registration Number
NCT03127982
Lead Sponsor
University of Los Andes, Columbia
Brief Summary

The present study aims at evaluating the effects of a CBT intervention, a cultural adaptation of the Unified Protocol for the Trans-diagnostic Treatment of Emotional Disorders (UP) in victims of the Colombian armed conflict.

A randomized clinical trial aimed at evaluating the effects of the UP in a group of 100 internally displaced victims of armed conflict living in Bogotá is being implemented. Participants are recruited from several governmental, non-governmental agencies as well as community organizations of victims. Participants are being randomly assigned to treatment condition (N=50) or to waiting-list control (N=50). Treatment consists in 12 biweekly sessions covering the 8 modules of the original UP. The effects of the UP is evaluated through Patient Health Questionnaire (PHQ) and several measures of co-morbid emotional disorders, Anxiety, Depression, PTSD as well as level of functioning and quality of life.

Detailed Description

Specific objectives

* To translate and adapt the UP, taking into account the cultural, social, economic and political context of individuals exposed to political violence in Colombia.

* Develop and adapt a set of assessment tools to identify victim's symptoms of anxiety, depression, and related disorders.

* Conduct a randomized clinical trial comparing outcomes of 12 biweekly sessions of the culturally adapted UP in a group participants randomized to immediate treatment to a waiting list control receiving delayed (6-week) treatment.

* To identify potential variables that mediate or moderate the effects of treatment with the UP.

Methodology Design. Allocation randomized Participants. 100 individuals presenting emotional sequelae of exposure to violent events of armed conflict in Colombia, 50 of which are being randomly assigned to treatment group and 50 to control group (waiting list).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
109
Inclusion Criteria
  • Inclusion criteria. Individuals registered as victims in Colombian Victims Unit, 18 years or older, who meet the diagnostic criteria for one or more anxiety disorder(s), depressive disorder(s) or post-traumatic stress and related disorder(s) according to the Diagnostic and Statistical Manual (DSM-5, 2013) as determined by the International Neuro-Psychiatric Interview M.I.N.I.
Exclusion Criteria
  • Exclusion criteria. Individuals diagnosed with psychotic disorders, bipolar affective disorders, intellectual disability, dementia, substance abuse (as primary diagnoses, with hospitalization requirement for treatment) as well as individuals who endorse acute suicidal risk. Those that do not meet the inclusion criteria, but are in need of mental health attention, will be referred to entities of the Health System, so that they receive the pertinent treatment.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group 2Unified ProtocolParticipants randomly assigned to this condition do not receive any active intervention during a six-week wait period after randomization, while completing assessment evaluation at the beginning and end of wait list period, after which they receive the same intervention (Unified Protocol) provided to the treatment condition (Group 1).
Group 1Unified ProtocolImmediately following randomization, participants in this condition attend 12-13 biweekly face-to face individual sessions that last approximately 1.5 hrs each of the cultural adaptation of the Unified Protocol trans diagnostic treatment comprising the following modules: motivation enhancement, psycho-education of emotion, emotion awareness training, cognitive reappraisal, emotion avoidance and emotion-driven behavior, tolerance training for physical sensations, emotion exposure, and relapse prevention. Treatment is provided by graduate students in clinical psychology who have been trained in the UP and receive weekly supervision by experienced clinicians and use a Workbook for homework assigned between sessions.
Primary Outcome Measures
NameTimeMethod
Changes in diagnostic criteria for depression, anxiety, as assessed by the Patient Health Questionnaire.Administered at baseline, post-treatment - on average 8 weeks after the beginning of treatment, and a 3-month follow-up.

PHQ - complete.

Change in symptoms of post-traumatic stress as measured by the Post-Traumatic Stress Disorder (PTSD)Administered at baseline, post-treatment - on average 8 weeks after the beginning of treatment, and a 3-month follow-up.

Checklist for the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) (PCL-5).

Secondary Outcome Measures
NameTimeMethod
Anxiety measure.Administered at baseline, post-treatment - on average 8 weeks after the beginning of treatment, and a 3-month follow-up.

Overall Anxiety Severity and Impairment Scale (OASIS)

Depression measure.Administered at baseline, post-treatment - on average 8 weeks after the beginning of treatment, and a 3-month follow-up.

Overall Depression Severity and Impairment Scale. (ODSIS).

Quality of Life. Self-reported measure assessing the physical health, subjective feelings, leisure activities, social relationships, general activities, satisfaction with medications and life satisfaction.Administered at baseline, post-treatment - on average 8 weeks after the beginning of treatment, and a 3-month follow-up.

Quality of Life Enjoyment Questionnaire, Q-LES-Q.

Current level of functioning.Baseline, and 3-month follow-up.

Current level of functioning measure. Adapted from ACOPLE. (Santaella-Tenorio J, Bonilla- Escobar FJ, Fandiño-Losada A, Bass J, Gutiérrez-Martínez MI, Bolton P. Validating an Instrument for victims of violence in Colombia: Evaluation of Two Community-based Mental Health Interventions for Violence-Displaced Afro-Descendants in Colombia. \[Unpublished manuscript\]. Colombia: University of Valle, Instituto CISALVA; 2013). -\[Time Frame: Baseline, and 3-month follow-up.

Trial Locations

Locations (1)

Laboratorio de Psicología Clínica Uniandes - Universidad de Los Andes

🇨🇴

Bogotá, DC, Colombia

© Copyright 2025. All Rights Reserved by MedPath